Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy

Deqiang Li, Ying Liu, Mitsunori Maruyama, Wuqiang Zhu, Hanying Chen, Wenjun Zhang, Sean Reuter, Shien-Fong Lin, Laura Haneline, Loren Field, Peng-Sheng Chen, Weinian Shou

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inheritable myocardial disorder associated with fibrofatty replacement of myocardium and ventricular arrhythmia. A subset of ARVC is categorized as Naxos disease, which is characterized by ARVC and a cutaneous disorder. A homozygous loss-of-function mutation of the Plakoglobin (Jup) gene, which encodes a major component of the desmosome and the adherens junction, had been identified in Naxos patients, although the underlying mechanism remained elusive. We generated Jup mutant mice by ablating Jup in cardiomyocytes. Jup mutant mice largely recapitulated the clinical manifestation of human ARVC: ventricular dilation and aneurysm, cardiac fibrosis, cardiac dysfunction and spontaneous ventricular arrhythmias. Ultra-structural analyses revealed that desmosomes were absent in Jup mutant myocardia, whereas adherens junctions and gap junctions were preserved. We found that ventricular arrhythmias were associated with progressive cardiomyopathy and fibrosis in Jup mutant hearts. Massive cell death contributed to the cardiomyocyte dropout in Jup mutant hearts. Despite the increase of β-catenin at adherens junctions in Jup mutant cardiomyoicytes, the Wnt/β-catenin-mediated signaling was not altered. Transforming growth factor-beta-mediated signaling was found significantly elevated in Jup mutant cardiomyocytes at the early stage of cardiomyopathy, suggesting an important pathogenic pathway for Jup-related ARVC. These findings have provided further insights for the pathogenesis of ARVC and potential therapeutic interventions.

Original languageEnglish
Article numberddr392
Pages (from-to)4582-4596
Number of pages15
JournalHuman Molecular Genetics
Volume20
Issue number23
DOIs
StatePublished - Dec 2011

Fingerprint

gamma Catenin
Arrhythmogenic Right Ventricular Dysplasia
Cardiomyopathies
Cardiac Myocytes
Adherens Junctions
Cardiac Arrhythmias
Catenins
Desmosomes
Myocardium
Fibrosis
Heart Aneurysm
Ventricular Dysfunction
Gap Junctions
Transforming Growth Factor beta
Dilatation
Cell Death
Skin
Mutation
Genes

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy. / Li, Deqiang; Liu, Ying; Maruyama, Mitsunori; Zhu, Wuqiang; Chen, Hanying; Zhang, Wenjun; Reuter, Sean; Lin, Shien-Fong; Haneline, Laura; Field, Loren; Chen, Peng-Sheng; Shou, Weinian.

In: Human Molecular Genetics, Vol. 20, No. 23, ddr392, 12.2011, p. 4582-4596.

Research output: Contribution to journalArticle

@article{16ebe55270cb47e984ccaa79586c3d60,
title = "Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy",
abstract = "Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inheritable myocardial disorder associated with fibrofatty replacement of myocardium and ventricular arrhythmia. A subset of ARVC is categorized as Naxos disease, which is characterized by ARVC and a cutaneous disorder. A homozygous loss-of-function mutation of the Plakoglobin (Jup) gene, which encodes a major component of the desmosome and the adherens junction, had been identified in Naxos patients, although the underlying mechanism remained elusive. We generated Jup mutant mice by ablating Jup in cardiomyocytes. Jup mutant mice largely recapitulated the clinical manifestation of human ARVC: ventricular dilation and aneurysm, cardiac fibrosis, cardiac dysfunction and spontaneous ventricular arrhythmias. Ultra-structural analyses revealed that desmosomes were absent in Jup mutant myocardia, whereas adherens junctions and gap junctions were preserved. We found that ventricular arrhythmias were associated with progressive cardiomyopathy and fibrosis in Jup mutant hearts. Massive cell death contributed to the cardiomyocyte dropout in Jup mutant hearts. Despite the increase of β-catenin at adherens junctions in Jup mutant cardiomyoicytes, the Wnt/β-catenin-mediated signaling was not altered. Transforming growth factor-beta-mediated signaling was found significantly elevated in Jup mutant cardiomyocytes at the early stage of cardiomyopathy, suggesting an important pathogenic pathway for Jup-related ARVC. These findings have provided further insights for the pathogenesis of ARVC and potential therapeutic interventions.",
author = "Deqiang Li and Ying Liu and Mitsunori Maruyama and Wuqiang Zhu and Hanying Chen and Wenjun Zhang and Sean Reuter and Shien-Fong Lin and Laura Haneline and Loren Field and Peng-Sheng Chen and Weinian Shou",
year = "2011",
month = "12",
doi = "10.1093/hmg/ddr392",
language = "English",
volume = "20",
pages = "4582--4596",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "23",

}

TY - JOUR

T1 - Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy

AU - Li, Deqiang

AU - Liu, Ying

AU - Maruyama, Mitsunori

AU - Zhu, Wuqiang

AU - Chen, Hanying

AU - Zhang, Wenjun

AU - Reuter, Sean

AU - Lin, Shien-Fong

AU - Haneline, Laura

AU - Field, Loren

AU - Chen, Peng-Sheng

AU - Shou, Weinian

PY - 2011/12

Y1 - 2011/12

N2 - Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inheritable myocardial disorder associated with fibrofatty replacement of myocardium and ventricular arrhythmia. A subset of ARVC is categorized as Naxos disease, which is characterized by ARVC and a cutaneous disorder. A homozygous loss-of-function mutation of the Plakoglobin (Jup) gene, which encodes a major component of the desmosome and the adherens junction, had been identified in Naxos patients, although the underlying mechanism remained elusive. We generated Jup mutant mice by ablating Jup in cardiomyocytes. Jup mutant mice largely recapitulated the clinical manifestation of human ARVC: ventricular dilation and aneurysm, cardiac fibrosis, cardiac dysfunction and spontaneous ventricular arrhythmias. Ultra-structural analyses revealed that desmosomes were absent in Jup mutant myocardia, whereas adherens junctions and gap junctions were preserved. We found that ventricular arrhythmias were associated with progressive cardiomyopathy and fibrosis in Jup mutant hearts. Massive cell death contributed to the cardiomyocyte dropout in Jup mutant hearts. Despite the increase of β-catenin at adherens junctions in Jup mutant cardiomyoicytes, the Wnt/β-catenin-mediated signaling was not altered. Transforming growth factor-beta-mediated signaling was found significantly elevated in Jup mutant cardiomyocytes at the early stage of cardiomyopathy, suggesting an important pathogenic pathway for Jup-related ARVC. These findings have provided further insights for the pathogenesis of ARVC and potential therapeutic interventions.

AB - Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inheritable myocardial disorder associated with fibrofatty replacement of myocardium and ventricular arrhythmia. A subset of ARVC is categorized as Naxos disease, which is characterized by ARVC and a cutaneous disorder. A homozygous loss-of-function mutation of the Plakoglobin (Jup) gene, which encodes a major component of the desmosome and the adherens junction, had been identified in Naxos patients, although the underlying mechanism remained elusive. We generated Jup mutant mice by ablating Jup in cardiomyocytes. Jup mutant mice largely recapitulated the clinical manifestation of human ARVC: ventricular dilation and aneurysm, cardiac fibrosis, cardiac dysfunction and spontaneous ventricular arrhythmias. Ultra-structural analyses revealed that desmosomes were absent in Jup mutant myocardia, whereas adherens junctions and gap junctions were preserved. We found that ventricular arrhythmias were associated with progressive cardiomyopathy and fibrosis in Jup mutant hearts. Massive cell death contributed to the cardiomyocyte dropout in Jup mutant hearts. Despite the increase of β-catenin at adherens junctions in Jup mutant cardiomyoicytes, the Wnt/β-catenin-mediated signaling was not altered. Transforming growth factor-beta-mediated signaling was found significantly elevated in Jup mutant cardiomyocytes at the early stage of cardiomyopathy, suggesting an important pathogenic pathway for Jup-related ARVC. These findings have provided further insights for the pathogenesis of ARVC and potential therapeutic interventions.

UR - http://www.scopus.com/inward/record.url?scp=81255209231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81255209231&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddr392

DO - 10.1093/hmg/ddr392

M3 - Article

VL - 20

SP - 4582

EP - 4596

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 23

M1 - ddr392

ER -